Pharma News

An experimental drug from Mirati Therapeutics Inc that targets a specific genetic mutation significantly reduced tumor size in 40% of patients with advanced lung and colorectal cancer so far evalu...

(Reuters) - Allergan Plc would pay $750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer’s disease therapy Namenda, the drugmaker said, in a resolution...

Working with model mice, post-mortem human brains, and people with schizophrenia, researchers at the RIKEN Center for Brain Science in Japan have discovered that a subtype of schizophrenia is related ...

Australian researchers have found little evidence that medicinal cannabis can relieve mental illnesses such as anxiety, depression and psychosis.

AVROBIO, Inc.

DUBLIN, Oct.

Drones can reach critically-ill patients three minutes faster than paramedics in busy cities, according to research.

Amgen's Repatha is facing competition from Regeneron and Sanofi's Praluent, and there could be a new rival in the cholesterol market soon.

GSK has nabbed an expanded FDA nod for Zejula use in recurrent ovarian cancer beyond those with BRCA mutations as long as the tumor have a homologous recombination deficiency.

Construction began in May on WuXi Biologics' €325 million biologics plant in Dundalk, Ireland which is forecast to employ up to 400 when it is finished in 2021.

Cancer drug innovation and Emerging Market sales underlie an upward rerating at AstraZeneca.

A test that can tell whether bacteria is resistant to antibiotics in just 45 minutes has been created by scientists.